An ad hoc committee under the auspices of the National Academies of Sciences, Engineering, and Medicine has been convened to develop a cross-sectoral governance framework for considering the potential benefits and risks that emerging science, technology, and innovation in health and medicine can bring to society. The framework will translate key ethics principles into the governance ecosystem, with a particular focus on justice, equity, and fairness.
The pace of innovation, increasing implications and risks of emerging technologies, and importance of multiple stakeholders to the research, development, oversight, and use of such advances requires a careful examination of governance approaches. The study is informed by the work of the National Academy of Medicine’s standing Committee on Emerging Science, Technology, and Innovation in Health and Medicine (CESTI), which over the past 2 years has been examining the implications of advances in health and medicine and articulating elements that may form part of a governance framework to guide the development and use of emerging technologies to maximize societal benefit.
The study committee will be co-chaired by Keith Wailoo, Ph.D, Henry Putnam University Professor of History and Public Affairs, Princeton University, and Keith R. Yamamoto, Ph.D., Vice Chancellor for Science Policy and Strategy and Professor of Cellular and Molecular Pharmacology the University of California, San Francisco and Director of Precision Medicine for UCSF. The committee’s final report will provide actionable guidance for how to manage the risks, benefits, and implications of new technologies and will recommend strategies to improve coordinated and equitable governance. The report is expected to be issued in the spring of 2023.
A complete roster of those nominated to serve on the committee and the option to subscribe for periodic updates is available here.
